Collectively, these data demonstrate that CREBBP and KMT2D orchestrate shared and unique regulatory networks in the GC and reveal a select group of enhancers that are only disrupted upon combined gene loss but not upon single gene depletion both in normal GC B cells and in human DLBCL. Here, KMT2D is linked to diffuse large B-cell lymphoma.